OptimizeRx Corp

Ownership Transactions Reported by 16 Insiders

Symbol
OPRX on Nasdaq
Location
260 Charles Street, Suite 302, Waltham, Massachusetts

Insiders trading volume in the past year

OptimizeRx Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William J. Febbo CEO, Director $6.05M Apr 18, 2024
Miriam Paramore President And Cso $5.57M Dec 2, 2021
Douglas P. Baker Chief Financial Officer $2.76M Oct 5, 2021
Stephen L. Silvestro Chief Commercial Officer $927K May 2, 2024
Gus D. Halas Director $866K Jun 5, 2024
Theresa Greco Chief Commercial Officer $759K Nov 1, 2023
James Paul Lang Director $728K Jun 5, 2024
Ellen Vos Director $672K Jun 5, 2024
Gregory D. Wasson Director $506K Jun 5, 2024
Patrick D. Spangler Director $486K Jun 5, 2024
Edward Stelmakh Cfo/Coo $478K Feb 15, 2024
Marion Odence-Ford General Counsel and CCO $327K -$60.8K -15.7% Mar 1, 2024
Doug Besch Chief Product Officer $260K Feb 15, 2024
Cathy Klema Director $139K Jun 7, 2024
Brian Clark McCarthy Chief Revenue Officer $102K Aug 2, 2024
Todd Inman Chief Technology Officer $30.5K Mar 1, 2023

Recent Insider Transactions by Companies or Individuals for OptimizeRx Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.